JRC Publications Repository

JRC Publications Repository >

Browsing by Author BRUCHERTSEIFER Frank

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:   
Sort by: In order: Results/Page Authors/Record:
Showing results 42 to 61 of 93
Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2013Half-lives of 221Fr, 217At, 213Bi, 213Po and 209Pb from the 225Ac decay seriesSULIMAN GABRIEL; POMME Stefaan; MAROULI Maria; VAN AMMEL Raf; STROH HEIKO; JOBBAGY Viktor; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos, et alArticles in Journals
2012High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneumRAUCH C; SEIDL C.; SCHLAPSCHY M; SKERRA A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE R.Articles in Journals
2013High Resolution microSPECT imaging of Bi-213DE SWART J; SEGBERS M; MORGENSTERN Alfred; VAN DER HAVE F; CHAN Ho-Sze; BERNDSEN S.c.; BRUCHERTSEIFER Frank; DE JONG Marion; BEEKMAN F.j.; KONIJNENBERG M.w.Contributions to Conferences
2010Immunoliposomal Delivery of 213Bi for Alpha-emitter Targeting of Metastatic Breast CancerLINGAPPA M.; SONG H.; THOMPSON S.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SGOUROS G.Articles in Journals
2007An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha TherapyZIELINSKA Barbara, et alArticles in Journals
2009In vitro and in vivo comparison of 226Th and 213Bi-labelled radioconjugates for target alpha therapyBRUCHERTSEIFER Frank, et alContributions to Conferences
2012In vitro evaluation of alpha-particle emitter Ac-225 for somatostatin receptor radiotherapyGRAF Franziska, et alContributions to Conferences
2009Intravesical a-Radioimmunotherapy with 213Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude MicePFOST Birgit, et alArticles in Journals
2010Investigation of Para-sulfonatocalix[n]arenes [n = 6, 8] as Potential Chelates for 230UMONTAVON Gilles, et alArticles in Journals
2010Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for 230U†MONTAVON Gilles, et alArticles in Journals
2013Measurement and modelling of the cross sections for the reaction 230Th(3He,3n)230UMORGENSTERN Alfred, et alArticles in Journals
2012Measurement of the 225Ac half-lifePOMME Stefaan, et alArticles in Journals
2014Microbicidal Power of Alpha Radiation in Sterilizing Germinating Bacillus anthracis SporesRIVERA J., et alArticles in Journals
2014Optimizing energy window settings for microSPECT of 213BiDE SWART J, et alContributions to Conferences
2014Optimizing labeling conditions of 213Bi somatostatin analogues for receptor mediated process in preclinical modelsCHAN Ho-Sze, et alContributions to Conferences
2012Orthotopic administration of 213Bi-Bevacizumab inhibits progression of PC3 xenografts in the prostateRIZVI S.m.a., et alArticles in Journals
2012Polymersomes as nano-carriers to retain harmful recoil nuclides in alpha radionuclide therapy: a feasibility studyTHIJSEN L., et alArticles in Journals
2008Production of 230U/226Th for Targeted Alpha Therapy via Proton Irradiation of 231PaMORGENSTERN Alfred, et alArticles in Journals
2008Production of Alpha Emitters for Targeted Alpha TherapyMORGENSTERN Alfred, et alArticles in Journals
2008Production of Alpha Emitting Radionuclides for Nuclear MedicineMORGENSTERN Alfred, et alArticles in books
Showing results 42 to 61 of 93

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top